Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses

Autor: Michel DuPage, Da-Yae Lee, Denise Crowley, Nikhil S. Joshi, Anna F. Farago, Yisi Lu, Amy Li, Tyler Jacks, Gregory P. Chang, Rebecca Robbins, Roderick T. Bronson, Elliot H. Akama-Garren, Natanya R. Kerper, Tuomas Tammela
Přispěvatelé: Massachusetts Institute of Technology. Department of Biology, Koch Institute for Integrative Cancer Research at MIT, Joshi, Nikhil, Akama-Garren, Elliot H., Lu, Yisi, Lee, Da-Yae, Chang, Gregory, Li, Amy, DuPage, Michel J., Tammela, Tuomas, Kerper, Natanya R., Farago, Anna F., Robbins, Rebecca, Crowley, Denise G., Jacks, Tyler E.
Rok vydání: 2015
Předmět:
Lung Neoplasms
T-Lymphocytes
Endogeny
Lymphocyte Activation
T-Lymphocytes
Regulatory

Transgenic
Mice
Neoplasms
2.1 Biological and endogenous factors
Immunology and Allergy
Lymphocytes
Aetiology
Lung
Cells
Cultured

Cancer
Microscopy
Microscopy
Confocal

Cultured
medicine.diagnostic_test
Lung Cancer
hemic and immune systems
Forkhead Transcription Factors
Flow Cytometry
Immunohistochemistry
Regulatory
medicine.anatomical_structure
Infectious Diseases
5.1 Pharmaceuticals
Confocal
Adenocarcinoma
Development of treatments and therapeutic interventions
Transgene
T cell
Cells
Immunology
Mice
Transgenic

chemical and pharmacologic phenomena
Biology
Article
Lymphocyte Depletion
Flow cytometry
Lymphocytes
Tumor-Infiltrating

Immune system
Rare Diseases
medicine
Animals
Tumor-Infiltrating
Cell Proliferation
Cell growth
Inflammatory and immune system
Dendritic Cells
medicine.disease
Luminescent Proteins
Immunization
Zdroj: Immunity, vol 43, iss 3
PMC
ISSN: 1074-7613
DOI: 10.1016/j.immuni.2015.08.006
Popis: Infiltration of regulatory T (Treg) cells into many tumor types correlates with poor patient prognoses. However, mechanisms of intratumoral Treg cell function remain to be elucidated. We investigated Treg cell function in a genetically-engineered mouse lung adenocarcinoma model and found Treg cells suppress anti-tumor responses in tumor-associated tertiary lymphoid structures (TA-TLS). TA-TLS have been described in human lung cancers, but their function remains to be determined. TLS in this model were spatially associated with >90% of tumors and facilitated interactions between T cells and tumor-antigen presenting dendritic cells (DCs). Costimulatory ligand expression by DCs and T cell proliferation rates increased in TA-TLS upon Treg cell depletion, leading to tumor destruction. Thus, we propose Treg cells in TA-TLS can inhibit endogenous immune responses against tumors, and targeting these cells may provide therapeutic benefit for cancer patients.
National Cancer Institute (U.S.) (Cancer Center Support Grant P30-CA14051)
Howard Hughes Medical Institute
National Institutes of Health (U.S.) (Grants 1 U54 CA126515-01, R01-CA185020-01 and T32 GM007753)
Damon Runyon Cancer Research Foundation
John D. Proctor Foundation (Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award)
Lung Cancer Research Foundation
Howard Hughes Medical Institute (Investigator)
Daniel K. Ludwig Scholar
Databáze: OpenAIRE